生物化工2024,Vol.10Issue(2) :231-233.

TREM2与神经退行性疾病

TREM2 and Neurodegenerative Diseases

曹璐 曾常茜
生物化工2024,Vol.10Issue(2) :231-233.

TREM2与神经退行性疾病

TREM2 and Neurodegenerative Diseases

曹璐 1曾常茜1
扫码查看

作者信息

  • 1. 大连大学 医学院,辽宁大连 116622
  • 折叠

摘要

2 型髓系细胞触发受体(TREM2)是主要表达于小胶质细胞的激活受体,研究发现TREM2 与DNAX相关蛋白12(DAP12)结合,可以调控小胶质细胞的激活与极化、降低炎症因子水平、减少神经元损伤.本文对TREM2 及其在阿尔兹海默症、帕金森病、癫痫、缺血性脑卒中和多发性硬化症等多种神经退行性疾病中的作用进行了概述.

Abstract

Triggering receptor expressed on myeloid cells-2(TREM2)is an activating receptor that is predominantly expressed in microglia.Studies have found that TREM2 binds to DNAX-related protein 12(DAP12)to regulate the activation and polarization of microglia,reduce the level of inflammatory factors,and reduce neuronal damage.This article provides an overview of TREM2 and its role in a variety of neurodegenerative diseases,including Alzheimer's disease,Parkinson's disease,epilepsy,ischemic stroke,and multiple sclerosis.

关键词

2型髓系细胞触发受体/神经退行性疾病/炎症

Key words

triggering receptor expresses on myeloid cells-2/neurodegenerative diseases/inflammation

引用本文复制引用

出版年

2024
生物化工

生物化工

ISSN:
参考文献量19
段落导航相关论文